|
|
|
|
Vol. 62, Issue 2, 257-264, August 2002
Department of Pharmacology and Toxicology, University of Western
Ontario (J.M.S., A.J.D., J.R.B.); Departments of Pediatrics,
Pharmacology and Toxicology, Child Health Research Institute, London,
Ontario, Canada (S.J.A.D.); and Faculty of Pharmacy and Pharmaceutical
Sciences, University of Alberta, Edmonton, Alberta, Canada
(A.O.S.E.-K.)
Elevated serum and tissue bilirubin concentrations that occur in
pathological conditions such as cholestasis, jaundice, and other liver
diseases are known to stimulate cytotoxic responses. In preliminary
studies, we noted that bilirubin seemed to cause apoptosis in murine
hepatoma Hepa 1c1c7 wild-type (WT) cells. Consequently, we investigated
apoptosis caused by bilirubin in WT, mutant C12 [aryl hydrocarbon
receptor (AHR)-deficient], and C4 (AHR nuclear translocator-deficient)
Hepa 1c1c7 cells. Three independent measures of apoptosis were used to
quantify the effects of exogenous bilirubin (0, 1, 10, 25, 50, or 100 µM). Caspase-3 activity and cytochrome c release from
mitochondria increased at 3 h post-treatment, before increased
caspase-8 activity at 6 h, and nuclear condensation by 24 h
after treatment with bilirubin. No differences in whole-cell lipid
peroxidation were observed between the cell types; however,
intracellular reactive oxygen species (ROS) production was greater in
WT cells than C12 or C4 cells 3 h after bilirubin exposure.
Pretreatment of cells for 1 h with 1 or 10 µM
-naphthoflavone, an AHR antagonist, before bilirubin exposure
resulted in decreased caspase-3 activity at 6 h and nuclear
condensation at 24 h in WT cells. These results indicate that
bilirubin, a potential AHR ligand, causes apoptosis in murine Hepa
1c1c7 WT cells by a mechanism(s) partially involving the AHR,
disruption of membrane integrity, and increased intracellular ROS production.
This article has been cited by other articles:
![]() |
Y. Zhang, H. El-Sikhry, K. R. Chaudhary, S. N. Batchu, A. Shayeganpour, T. O. Jukar, J. A. Bradbury, J. P. Graves, L. M. DeGraff, P. Myers, et al. Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H37 - H46. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Fong, L. D. Burgoon, and T. R. Zacharewski Comparative Microarray Analysis of Basal Gene Expression in Mouse Hepa-1c1c7 Wild-Type and Mutant Cell Lines Toxicol. Sci., August 1, 2005; 86(2): 342 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kapitulnik Bilirubin: An Endogenous Product of Heme Degradation with Both Cytotoxic and Cytoprotective Properties Mol. Pharmacol., October 1, 2004; 66(4): 773 - 779. [Full Text] [PDF] |
||||